Vilchis-Ramírez M, Álvarez-Martínez F, Tena-Sanabria M, Fuentes-Herrera G

Language: Spanish
References: 11
Page: 309-313
PDF size: 212.08 Kb.

ABSTRACT

Introduction: parosteal osteosarcoma is an extramedullary malignant bone tumor in which cells produce osteoid, represents less than 5% of all osteosarcomas, it occurs predominantly in women between the second and fourth decade of life. It is often located in the distal region of the femur and proximal tibia. Clinically it presents with increased volume and thigh or knee pain. Due to its low incidence and clinical features, a clinical case of femoral parosteal osteosarcoma is presented, with description of the surgical technique performed. Case report: a 14-year-old female presented with a 6-month history of increased volume and right thigh pain. Radiological studies revealed a bone lesion with malignant characteristics, for which she was sent to third-level hospital where oncology study protocol was set up; consisting in two percutaneous biopsies of the lesion with Jamshidi needle, which were histopathology reported as negative for malignant cells. The pulmonary high-resolution computed tomography showed metastasis and a Tc-99m MDP bone scintigraphy showed increased osteoblastic activity in the right femoral shaft. Given the results, is confirmed the need of en-bloc resection and intercalary prosthesis implantation with adjuvant chemotherapy. Conclusion: the intercalary prosthesis is a suitable therapeutic option in limb-salvage surgery for patients with femoral parosteal osteosarcoma.

REFERENCES

1. Kumar VS, Barwar N, Khan SA. Surface osteosarcomas: diagnosis, treatment and outcome. Indian J Orthop. 2014; 48(3): 255-61.

2. Nouri H, Ben Maitigue M, Abid L, Nouri N, Abdelkader A, Bouaziz M, et al. Surface osteosarcoma: clinical features and therapeutic implications. J Bone Oncol. 2015; 4(4): 115-23.

3. Sánchez-Torres LJ, Santos-Hernández M. Osteosarcoma. Rev Mex Ortop Ped. 2011; 13(1): 10-9.

4. Lin HY, Hondar Wu HT, Wu PK, Wu CL, Chih-Hsueh Chen P, Chen WM, et al. Can imaging distinguish between low-grade and dedifferentiated parosteal osteosarcoma? J Chin Med Assoc. 2018; 81(10): 912-9.

5. Laitinen M, Parry M, Albergo JI, Jeys L, Abudu A, Carter S, et al. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma. Bone Joint J. 2015; 97-B(12): 1698-703.

6. Clara-Altamirano MA, García-Ortega DY, Martínez-Tlahuel JL, Martínez-Said H, Caro-Sánchez CHS, García-Ruíz GC, et al. Osteosarcoma con presentación atípica en tercio medio de diáfisis de fémur. Reporte de un caso clínico y revisión de la literatura. Acta Ortop Mex. 2016; 30(1): 28-32.

7. Yoshida A. Osteosarcoma: Old and new challenges. Surg Pathol Clin. 2021; 14(4): 567-83.

8. Mei J, Zhu XZ, Wang ZY, Cai XS. Functional outcomes and quality of life in patients with osteosarcoma treated with amputation versus limb-salvage surgery: a systematic review and meta-analysis. Arch Orthop Trauma Surg. 2014; 134(11): 1507-16.

9. Ahlmann ER, Menendez LR. Intercalary endoprosthetic reconstruction for diaphyseal bone tumours. J Bone Joint Surg Br. 2006; 88(11): 1487-91.

10. Chen TH, Chen WM, Huang CK. Reconstruction after intercalary resection of malignant bone tumours: comparison between segmental allograft and extracorporeally-irradiated autograft. J Bone Joint Surg Br. 2005; 87(5): 704-9.

11. Delgadillo-Alcaráz V, Cuevas-De Alba C, Flores-Navarro HH, Arana-Hernández EI, Gutiérrez-Ureña JA. Preservación de extremidad con aloinjerto óseo en un paciente pediátrico con osteosarcoma. Rev Med MD. 2018; 9(3): 275-8.